This condition, formerly known as PCOS (polycystic ovary syndrome), is often tied to insulin resistance and higher levels of androgens (so-called male sex hormones like testosterone that female bodies typically produce at low levels)
doi:10.3390/receptors4010002 138
The objective was to evaluate the effectiveness and safety, with a specific focus on cardiovascular safety, of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, compared to insulin glargine in adults with type 2 diabetes and a high risk of cardiovascular events who have not achieved adequate control with oral glucose-lowering medications.This phase 3 study was conducted at 187 sites across 14 countries on five continents
It is not approved for use in weight loss management
When there were two symptoms, fatigue was always one of them
At THE RE/ CLINIC in Sandy, Utah, were here to provide clear, medically informed answers to help you make the best decisions for your health